Literature DB >> 20977666

Wisely chosen paths--regulation of rRNA synthesis: delivered on 30 June 2010 at the 35th FEBS Congress in Gothenburg, Sweden.

Ingrid Grummt1.   

Abstract

All cells, from prokaryotes to vertebrates, synthesize enormous amounts of rRNA to produce 1-2 million ribosomes per cell cycle, which are required to maintain the protein synthesis capacity of the daughter cells. In recent years, considerable progress has been made in the elucidation of the basic principles of transcriptional regulation and the pathways that adapt cellular rRNA synthesis to metabolic activity, a process that is essential for understanding the link between nucleolar activity, cell growth, proliferation, and apoptosis. I will survey our present knowledge of the highly coordinated networks that regulate transcription by RNA polymerase I, coordinating rRNA gene transcription and ribosome production with environmental cues. Moreover, I will discuss the epigenetic mechanisms that control the chromatin structure and transcriptional activity of rRNA genes, in particular the role of noncoding RNA in DNA methylation and transcriptional silencing.
© 2010 The Author Journal compilation © 2010 FEBS.

Mesh:

Substances:

Year:  2010        PMID: 20977666     DOI: 10.1111/j.1742-4658.2010.07892.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  37 in total

1.  CRM1 and its ribosome export adaptor NMD3 localize to the nucleolus and affect rRNA synthesis.

Authors:  Baoyan Bai; Henna M Moore; Marikki Laiho
Journal:  Nucleus       Date:  2013-06-12       Impact factor: 4.197

Review 2.  The nucleolus—guardian of cellular homeostasis and genome integrity.

Authors:  Ingrid Grummt
Journal:  Chromosoma       Date:  2013-12       Impact factor: 4.316

Review 3.  Noncoding RNAs in eukaryotic ribosome biogenesis and function.

Authors:  Denis L J Lafontaine
Journal:  Nat Struct Mol Biol       Date:  2015-01       Impact factor: 15.369

4.  pRNA: NoRC-associated RNA of rRNA operons.

Authors:  Stefanie Wehner; Anja K Dörrich; Philipp Ciba; Annegret Wilde; Manja Marz
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

5.  Small molecule BMH-compounds that inhibit RNA polymerase I and cause nucleolar stress.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Sari Jäämaa; Zhewei Zhang; Taija Af Hällström; Henna M Moore; Paul Sirajuddin; Marikki Laiho
Journal:  Mol Cancer Ther       Date:  2014-10-02       Impact factor: 6.261

6.  Severe neurodegenerative disease in brothers with homozygous mutation in POLR1A.

Authors:  Bülent Kara; Çiğdem Köroğlu; Karita Peltonen; Ruchama C Steinberg; Hülya Maraş Genç; Maarit Hölttä-Vuori; Ayşe Güven; Kristiina Kanerva; Tuğba Kotil; Seyhun Solakoğlu; You Zhou; Vesa M Olkkonen; Elina Ikonen; Marikki Laiho; Aslıhan Tolun
Journal:  Eur J Hum Genet       Date:  2017-01-04       Impact factor: 4.246

7.  Loss of BRMS2 induces cell growth inhibition and translation capacity reduction in colorectal cancer cells.

Authors:  Yaofu Liu; Weimin Xu; Xin Xu; Zhengzhi Tan; Jing Xu; Lei Ma; Peng Du; Yili Yang
Journal:  Am J Cancer Res       Date:  2021-03-01       Impact factor: 6.166

8.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

Review 9.  Dysregulation of RNA polymerase I transcription during disease.

Authors:  K M Hannan; E Sanij; L I Rothblum; R D Hannan; R B Pearson
Journal:  Biochim Biophys Acta       Date:  2012-11-12

10.  Effective targeting of RNA polymerase I in treatment-resistant prostate cancer.

Authors:  Jin-Yih Low; Paul Sirajuddin; Michael Moubarek; Shreya Agarwal; Apurv Rege; Gunes Guner; Hester Liu; Zhiming Yang; Angelo M De Marzo; Charles Bieberich; Marikki Laiho
Journal:  Prostate       Date:  2019-09-16       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.